Pale Fire Capital SE »

Akebia Therapeutics shares owned by Pale Fire Capital SE

Quarter-by-quarter ownership of Akebia Therapeutics (AKBA) shares owned by Pale Fire Capital SE from 13F filings

Historical chart of Pale Fire Capital SE investment in Akebia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Akebia Therapeutics held by Pale Fire Capital SE consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Akebia Therapeutics by Pale Fire Capital SE

Quarter filed Position value Share count Share price at filing
2025-09-30 $137k 50k 2.73

More positions owned by Pale Fire Capital SE

B2gold Corp (BTG)
Groupon Com New (GRPN)
Dole Ord Shs (DOLE)
Iamgold Corp (IAG)
New Gold Inc Cda (NGD)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Centerra Gold (CGAU)
Angi Cl A New (ANGI)
I-80 Gold Corp (IAUX)
Mineralys Therapeutics (MLYS)
J Global (ZD)
Galiano Gold (GAU)
Tsakos Energy Navigation SHS (TEN)
Atai Life Sciences Nv SHS (ATAI)
Liquidia Corporation Com New (LQDA)

View all positions for Pale Fire Capital SE

Top funds holding Akebia Therapeutics

BlackRock
Vanguard Group
State Street Corporation
Geode Capital Management
Morgan Stanley
Renaissance Technologies
UBS Group
Citadel Advisors
Qube Research & Technologies
MPM Oncology Impact Management
Millennium Management
Franklin Resources
Northern Trust
Affinity Asset Advisors
Invesco

View all funds holding Akebia Therapeutics